According to a report by Fairfield Market Research, the global nuclear medicine market is expected to see significant growth in the coming years, with an estimated valuation of US$11.1 billion by 2030. The market is driven by factors such as the rising prevalence of cardiac disorders and cancers, technological advancements, and increasing research and development efforts. The market is segmented by product type, application, and end user. North America is currently the largest market for nuclear medicine, while the Asia Pacific region is expected to experience substantial growth. Key players in the industry include Advanced Accelerator Applications, Norgine B.V., Blue Earth Diagnostics Ltd., and Cardinal Health. Despite challenges such as shorter shelf-lives, high equipment costs, and budget constraints, the nuclear medicine market continues to thrive due to its growing role in disease identification and treatment.
Tue, 12 Dec 2023 15:10:00 GMT | Yahoo Finance